ESSA Pharma Inc.·4

Jul 5, 1:39 PM ET

Parkinson David Ross 4

4 · ESSA Pharma Inc. · Filed Jul 5, 2022

Insider Transaction Report

Form 4
Period: 2022-06-30
Parkinson David Ross
DirectorPresident and CEO
Transactions
  • Purchase

    Common Shares

    2022-06-30$2.96/sh+4,887$14,45632,108 total
Footnotes (1)
  • [F1]Shares purchased through the Issuer's Employee Share Purchase Plan.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION